Het Wilhelmina Ziekenhuis Assen is een ziekenhuis in de Nederlandse stad Assen. Het is een algemeen ziekenhuis, wat betekent dat er brede basiszorg wordt verleend en de verpleging en verzorging die daarmee te maken heeft.

During the past decade, Wilhelmina Ziekenhuis conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilhelmina Ziekenhuis" #1 sponsor was "University Medical Center Groningen" with 4 trials, followed by "Dutch Colorectal Cancer Group" with 3 trials sponsored, "The Netherlands Cancer Institute" with 3 trials sponsored, "UMC Utrecht" with 3 trials sponsored and "Amsterdam UMC, location VUmc" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilhelmina Ziekenhuis" #1 collaborator was "Borstkanker Onderzoek Groep" with 2 trials as a collaborator, "Cephalon" with 2 trials as a collaborator, "Innovatiefonds Zorgverzekeraars" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator and "UMC Utrecht" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Wilhelmina Ziekenhuis" are "Breast Cancer" (5 trials), "Breast Neoplasm" (2 trials), "Colon Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Wilhelmina Ziekenhuis" in a lesser frequency.

Most popular intervention types in "Wilhelmina Ziekenhuis" are "Drug" (16 trials), "Other" (10 trials), "Procedure" (4 trials), "Behavioral" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "AT1 blocker candesartan" (1 trials), "Acetylsalicylic acid" (1 trials) and "Antibiotic Stewardship Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wilhelmina Ziekenhuis" are 27 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Wilhelmina Ziekenhuis". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Wilhelmina Ziekenhuis, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wilhelmina Ziekenhuis, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".